XML 33 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Unrealized Gain/Loss
Accumulated Deficit
IPO
IPO
Additional Paid-In Capital
Series A redeemable convertible preferred stock
Series B redeemable convertible preferred stock
Series C redeemable convertible preferred stock
2012 Series X Redeemable Convertible Preferred Stock
Balance at Dec. 31, 2012 $ (59,588)         $ (59,588)            
Balance, shares at Dec. 31, 2012   615,757                    
Balance at Dec. 31, 2012                 $ 37,092 $ 19,816    
Balance, shares at Dec. 31, 2012                 734,538 1,287,525    
Issuance of restricted common stock, shares   583,126                    
Issuance of common stock, net of issuance costs, shares   176,717                    
Exercise of stock options, shares   14,357                    
Exercise of stock options 5   $ 5                  
Forfeitures of restricted common stock, shares   (6,612)                    
Reclassification of 2012 Series X preferred stock upon modification                       $ 2,486
Reclassification of 2012 Series X preferred stock upon modification, shares                       25,000
Sale of preferred stock, net of issuance cost                     $ 40,088 $ 2,458
Sale of preferred stock, net of issuance cost, shares                     2,945,742 25,000
Conversion of preferred stock, shares                     357,143 (50,000)
Conversion of preferred stock                     $ 4,944 $ (4,944)
Accretion of preferred stock to redemption value                 $ 2,275 $ 1,441 52,170  
Accretion of preferred stock to redemption value (55,886)   (1,569)     (54,317)            
Share-based compensation expense 1,564   1,564                  
Net income (loss) (13,167)         (13,167)            
Balance at Dec. 31, 2013 (127,072)         (127,072)            
Balance, shares at Dec. 31, 2013   1,383,345                    
Balance at Dec. 31, 2013                 $ 39,367 $ 21,257 $ 97,203  
Balance, shares at Dec. 31, 2013                 734,538 1,287,525 3,302,885  
Issuance of restricted common stock, shares   56,000                    
Issuance of common stock, net of issuance costs 114,954   114,954                  
Issuance of common stock, net of issuance costs, shares   6,762,000                    
Receipt of payment on promissory notes issued in exchange for shares of common stock 237   237                  
Exercise of stock options, shares   116,394                    
Exercise of stock options 89   89                  
Forfeitures of restricted common stock, shares   (53,835)                    
Conversion of preferred stock, shares   12,115,183             (734,538) (1,287,525) (3,302,885)  
Conversion of preferred stock 244,727   180,057     64,670     $ (74,188) $ (45,514) $ (125,025)  
Accretion of preferred stock to redemption value                 $ 34,821 $ 24,257 $ 27,822  
Accretion of preferred stock to redemption value (86,900)   (85,663)     (1,237)            
Share-based compensation expense 6,010   6,010                  
Deferred offering costs- IPO             $ (10,715) $ (10,715)        
Unrealized gain/loss (56)       $ (56)              
Treasury shares purchased, not retired( 2,553) (94)     $ (94)                
Treasury shares purchased, not retired in shares   (2,553)                    
Treasury shares purchased, retired (5,910) (68)     (68)                
Treasury shares purchased, retired in shares   (5,910)                    
Net income (loss) (37,034)         (37,034)            
Balance at Dec. 31, 2014 $ 104,078   204,969 (162) (56) (100,673)            
Balance, shares at Dec. 31, 2014 20,370,624 20,370,624                    
Issuance of common stock, net of issuance costs $ 82,750   82,750                  
Issuance of common stock, net of issuance costs, shares   10,083,070                    
Exercise of stock options, shares 218,674 218,674                    
Exercise of stock options $ 130   130                  
Proceeds from sale of stock under employee stock purchase plan 220   220                  
Proceeds from sale of stock under employee stock purchase plan, shares   25,903                    
Forfeitures of restricted common stock, shares   (36,053)                    
Share-based compensation expense 4,714   4,714                  
Unrealized gain/loss (178)       (178)              
Net income (loss) (60,716)         (60,716)            
Balance at Dec. 31, 2015 $ 130,998   $ 292,783 $ (162) $ (234) $ (161,389)            
Balance, shares at Dec. 31, 2015 30,662,218 30,662,218